0001022079-20-000002.txt : 20200103
0001022079-20-000002.hdr.sgml : 20200103
20200103163920
ACCESSION NUMBER: 0001022079-20-000002
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200102
FILED AS OF DATE: 20200103
DATE AS OF CHANGE: 20200103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Davis J. E.
CENTRAL INDEX KEY: 0001599837
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12215
FILM NUMBER: 20506152
MAIL ADDRESS:
STREET 1: C/O QUEST DIAGNOSTICS
STREET 2: 500 PLAZA DRIVE
CITY: SECAUCUS
STATE: NJ
ZIP: 07094
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: QUEST DIAGNOSTICS INC
CENTRAL INDEX KEY: 0001022079
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 161387862
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 500 PLAZA DRIVE
CITY: SECAUCUS
STATE: NJ
ZIP: 07094
BUSINESS PHONE: 9735202700
MAIL ADDRESS:
STREET 1: 500 PLAZA DRIVE
CITY: SECAUCUS
STATE: NJ
ZIP: 07094
FORMER COMPANY:
FORMER CONFORMED NAME: CORNING CLINICAL LABORATORIES INC
DATE OF NAME CHANGE: 19960903
4
1
wf-form4_157808754276203.xml
FORM 4
X0306
4
2020-01-02
0
0001022079
QUEST DIAGNOSTICS INC
DGX
0001599837
Davis J. E.
500 PLAZA DRIVE
SECAUCUS
NJ
07094
0
1
0
0
EVP, General Diagnostics
Common Stock
2020-01-02
4
M
0
65681
71.17
A
102215
D
Common Stock
2020-01-02
4
M
0
77865
66.51
A
180080
D
Common Stock
2020-01-02
4
S
0
58258
105.458
D
121822
D
Common Stock
2020-01-02
4
S
0
7423
106.513
D
114399
D
Common Stock
2020-01-02
4
S
0
69003
105.452
D
45396
D
Common Stock
2020-01-02
4
S
0
8853
106.511
D
36543
D
Non-Qualifed Stock Option (right to buy)
71.17
2020-01-02
4
M
0
65681
71.17
D
2025-02-23
Common Stock
65681.0
0
D
Non-Qualifed Stock Option (right to buy)
66.51
2020-01-02
4
M
0
77865
66.51
D
2026-02-25
Common Stock
77865.0
0
D
This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on November 26, 2019.
This transaction was executed in multiple trades at prices ranging from $105.00 to $105.99. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $106.00 to $106.82. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $105.00 to $106.00. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $106.01 to $106.82. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The options vested in three equal annual installments beginning with the first on February 23, 2016, the second on February 23, 2017 and the final on February 23, 2018.
The options vested in three equal annual installments beginning with the first on February 25, 2017, the second on February 25, 2018 and the final on February 25, 2019.
/s/ William J. O'Shaughnessy, Jr., attorney-in-fact for James E. Davis
2020-01-03